CAS RN: 51130-63-3
8-Oxa-1-aza-spiro[4.5]decane
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20251007
250mg
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 51130-63-3
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
51130-63-3 / 8-oxa-1-azaspiro[4.5]decane
Standard CAS: 51130-63-3
Multi CAS: No
Basic Information
copy
CAS
51130-63-3 copy
Multi CAS
No copy
Molecular Formula
C8H15NO copy
Molecular Weight
141.210000 copy
Exact Mass
141.115364 copy
InChI
InChI=1S/C8H15NO/c1-2-8(9-5-1)3-6-10-7-4-8/h9H,1-7H2 copy
InChIKey
FDDQZACIAJOJFY-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
10 copy
Fraction Csp3
1 copy
H-bond acceptors
2 copy
H-bond donors
1 copy
Molar refractivity
40.02 copy
TPSA
21.26 copy
LogP / Solubility
WLOGP
0.92 copy
MLOGP
0.8 copy
XLogP3
0.5 copy
Consensus LogP
0.74 copy
Log S (ESOL)
-1.29 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-1.38 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.34 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.93 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2.5 copy